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Introduction: Hypocomplementemic urticarial vasculitis syndrome is a rare disorder characterized by chronic
urticarial vasculitis, arthralgia, arthritis, and hypocomplementemia. Previously, only six patients with concomitant
hypocomplementemic urticarial vasculitis syndrome, Jaccoud’s arthropathy, and valvular heart disease have been
reported.
Case presentation: A 30-year-old Korean man presented with hypocomplementemic urticarial vasculitis syndrome.
In addition to urticarial cutaneous lesions, he experienced polyarthralgia and arthritis that resulted in progressive
deformity of the joints of both hands, cardiac valvulopathy with mitral, tricuspid, and aortic regurgitation, and
intermittent neck swelling with laryngeal edema. He also developed nephritis with azotemia. His renal biopsy results
revealed membranoproliferative glomerulonephritis, type I. He showed a partial response to a combination therapy
of steroid, cyclophosphamide, and mycophenolate mofetil.
Conclusions: We describe, to the best of our knowledge, the first case of glomerulonephritis presenting a
arthropathy and cardiac valvulopathy in hypocomplementemic urticarial vasculitis syndrome. A combination of
corticosteroids, cyclophosphamide, and mycophenolate mofetil appear to be a safe and effective treatment for
nephropathy, however are less effective for cutaneous vasculitis, cardiac valvulopathy, and arthropathy.
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Hypocomplementemic urticarial vasculitis syndrome
(HUVS) is a rare disorder characterized by chronic urti-
carial vasculitis, arthralgia, arthritis, and activation of the
classical complement pathway. Most patients have auto-
antibodies to C1q [1]. Previously, only six patients with
concomitant HUVS, Jaccoud’s arthropathy, and valvular
heart disease have been reported [2-5]. In this case, we de-
scribe a 30-year-old Korean man with this rare combin-
ation of symptoms, as well as azotemia secondary to
membranoproliferative glomerulonephritis.* Correspondence: hcjungmd@uuh.ulsan.kr
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A 30-year-old Korean man presented to our hospital
with recurrent urticarial lesions and joint pain for one
year previous. The urticarial lesions resolved with hyper-
pigmentation or residual purpura. The arthralgias were
intermittent and migratory, affecting the hands, knees,
and ankles, and resolved spontaneously after 2 to 3 days.
He did not smoke, denied any use of alcohol or herbal
remedies, and had no family history of autoimmune dis-
ease. On examination diffusely scattered, variably sized
erythematous pruritic papules were noted on his trunk
and extremities. Laboratory test results revealed his levels
of blood urea nitrogen (BUN) to be 12.3mg/dL, serum
creatinine 1.09mg/dL, C-reactive protein 1.167mg/L, and
rheumatoid factor (RF) <2.5IU/mL (normal range between. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cyclic citrullinated peptide antibody (anti-CCP), antinu-
clear antibodies (ANA) titer 1:40, speckled type, and the
HLA-B27 genotype was negative, and his erythrocyte
sedimentation rate (ESR) was 21mm/h. No cartilage or
bone destruction was detected on radiographs of his
hands. He was diagnosed with rheumatoid factor-negative
rheumatoid arthritis with skin vasculitis and was treated
with prednisolone, hydroxychloroquine, methotrexate, and
non-steroidal anti-inflammatory drugs.
Two years after his initial visit, he was admitted to our
hospital due to a worsening skin rash, right flank pain,
and upper abdominal pain unresponsive to medication.
His blood pressure was 148/80mm Hg, his heart rate
was regular at 76 beats/min, and his body temperature
was 36.3°C. He had diffuse urticarial lesions on his face,
trunk, and upper arms (Figure 1). A skin biopsy of a
new urticarial lesion revealed leukocytoclastic vasculitis.
An abdominal computed tomography (CT) scan re-
vealed multifocal low-attenuated lesions in both kidneys
without other abnormalities. A laboratory workup showedFigure 1 Urticarial rash and hyperpigmentation.his levels of total protein to be 5.7g/dL, albumin 3.3g/dL,
BUN 21mg/dL, creatinine 1.38mg/dL, D-dimer 3.5μg/mL
(normal range, 0 to 1μg/mL), fibrinogen 481mg/dL
(normal range, 200 to 400mg/dL), lactate dehydrogenase
751IU/L (normal range 218 to 472IU/L), C-reactive pro-
tein 5.261mg/L, normal prothrombin time and activated
partial thromboplastin time; antithrombin III 90% (normal
range, 80 to 120%), normal protein C and S activities, and
his ESR was 31mm/h.
He was found to be negative for ANA, anti-double-
stranded DNA antibody, anti-Smith antibody, anti-SS-A/
SS-B, lupus anticoagulant, antistreptolysin O, and anti-
neutrophil cytoplasmic antibody (ANCA). The concen-
trations of serum IgG, IgA, and IgM were normal. His
C3 level was 12.2mg/dL (normal range 90 to 180mg/dL),
C4 level <1.5mg/dL (normal range 10 to 40mg/dL), and
CH50 level 4.2U/mL (normal range 23 to 46U/mL), and
his cryoglobulin test result was negative. His serological
test results for hepatitis B and C viruses were also nega-
tive. His urine analysis showed trace protein, red blood
cell (RBC) count 0 to 1/high-power field (HPF), and a
urine protein-creatinine ratio of 364.4mg/g. A chest
radiograph showed no abnormalities. An echocardio-
gram showed moderate mitral and tricuspid regurgita-
tion with moderate-to-severe aortic regurgitation. There
was diastolic left ventricular dysfunction and normal left
ventricular systolic function. An aortography, superior
mesenteric, celiac, and bilateral renal arteriography
revealed no abnormalities. High-dose oral prednisolone
(1mg/kg) was administered for the treatment of active
vasculitis. His abdominal pain and skin lesions subsequently
improved.
One year after continuous treatment with steroid and
azathioprine therapy, he was readmitted due to bouts of
repeated deep neck swelling, laryngeal edema, and fever.
Symptoms were alleviated with antibiotics and fluid
therapy, but no causative organism was identified. After
his fever resolved, he developed slow progressive azote-
mia, proteinuria, and microscopic hematuria. An exam-
ination revealed swelling of the proximal interphalangeal
joints of both hands with swan neck and flexion deformities
(Figure 2). His laboratory tests showed his hemoglobin
level to be 8.8g/dL, white blood cell count 4340/μL
(neutrophils 71%), platelet count 56×103/μL, total protein
level 6.0g/dL, albumin level 3.1g/dL, BUN level 22mg/dL,
creatinine level 1.99mg/dL, and C-reactive protein level
2.875mg/L. His C3 level was 9.0mg/dL (normal range 90
to 180mg/dL), C4 level was <1.5mg/dL (normal range 10
to 40mg/dL), CH50 level was <2.0U/mL (normal range 23
to 46U/mL), and C1q level was 5.02mg/dL (normal range
11.8 to 23.8mg/dL). A urine analysis showed protein 1+,
red blood cell count 1 to 3/high-power field (HPF), and
urine protein-creatinine ratio of 1470.6mg/g. The 24-hour
urine protein level was 1.6g/day. A percutaneous renal
Figure 2 Swelling of the proximal interphalangeal joints with swan neck and flexion deformities of both hands.
Figure 3 Findings of kidney biopsy. (A) The mesangium was
expanded due to increased matrix without hypercellularity. The
glomerular capillary walls were mildly thickened. Peridic acid-Schiff
(PAS) stain; original magnification ×400. (B) Electron microscopy
shows irregular electron dense deposits in the subendothelial and
paramesangial space.
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contained 12 glomeruli and 2 arteries up to interlobular
size. The glomeruli were enlarged. The mesangium was
focally expanded due to an increase of the matrix without
hypercellularity and the glomerular capillary walls were
mildly thickened. There were patchy areas of interstitial
inflammation with mostly mononuclear cells and fibrosis.
The tubules showed degenerative changes of the epithelial
cells with proteinaceous casts and atrophy and the blood
vessels showed arteriolosclerosis. Immunofluorescent stain-
ing revealed granular deposits of IgG(++), IgM(+), C3(+/−),
C1q(+/−), and C4d(+++) along the capillary loop. An elec-
tron microscopy revealed some irregular electron dense
deposits in the subendothelial and paramesangial space.
His renal biopsy results were compatible with membrano-
proliferative glomerulonephritis type I (MPGN type I)
(Figure 3A,B). He was diagnosed with HUVS with cardiac
valvulopathy, Jaccoud’s arthropathy, and MPGN type I.
Three daily doses of intravenous methylprednisolone
(500mg each) were administered, followed by oral prednis-
one (1mg/kg/day) and cyclophosphamide (0.8mg/kg/day).
After six months of cyclophosphamide treatment, his
treatment was maintained with prednisolone (15mg/
day), hydroxychloroquine (400mg/day), and mycopheno-
late mofetil (MMF, 1.5g/day). His serum creatinine was
1.56mg/dL, his urine analysis showed protein 1+, his red
blood cell count was 1 to 3/HPF, and he had a urine
protein-creatinine ratio of 291.7mg/g. He remained mark-
edly hypocomplementemic, and continued with slowly
progressive severe arthropathy of the hands, despite im-
proved nephropathy.
Discussion
HUVS is a rare type of vasculitis first described in 1973
by McDuffie et al. [6] characterized clinically by recur-
rent urticaria with a variety of systemic manifestations.
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nostic criteria [7]. Two major criteria (recurrent urticaria
lasting longer than six months and hypocomplemente-
mia) and at least two minor criteria (venulitis on skin bi-
opsy, arthralgias or arthritis, glomerulonephritis, ocular
inflammation, abdominal pain, and positive C1q anti-
bodies) are required for the diagnosis of HUVS. In some
patients, HUVS may be secondary to underlying sys-
temic lupus erythematosus (SLE), Sjogren syndrome, or
neoplasia [8,9].
Our patient matched the criteria for HUVS on the
basis of the clinical findings of recurrent urticaria, arth-
ritis, and abdominal pain, as well as laboratory findings
of marked continuous hypocomplementemia and patho-
logical findings of cutaneous vasculitis and glomerulo-
nephritis, in the absence of any other secondary cause.
HUVS primarily occurs in young women, with onset
between 23 and 66 years of age with a peak incidence in
the fourth decade of life [1,10]. Obstructive lung disease,
angioedema, ocular inflammation, and glomeruloneph-
ritis are common manifestations in HUVS [11]. Lung
disease is the principal cause of morbidity and mortality.
Wisnieski et al. [1] described 18 patients with HUVS;
50% of patients had renal involvement that varied from
minimal proteinuria to nephrotic syndrome. Six renal bi-
opsies were performed; three cases showed mesangial
proliferative glomerulonephritis, two showed MPGN,
and one showed membranous nephropathy [1].
There is no consensus on the appropriate treatment of
HUVS. Corticosteroid therapy is reportedly effective in
many cases of HUVS [11,12], though several cases in
adults have progressed to end-stage renal disease [13].
Our patient developed MPGN three years after initial pres-
entation, despite corticosteroid and azathioprine therapy.
He continued with progressive worsening of kidney func-
tion. He subsequently showed a partial response to a com-
bination of corticosteroids, cyclophosphamide, and MMF.
Some patients with HUVS have had concomitant car-
diac valvulopathy and Jaccoud’s arthropathy. In 1993,
Palazzo et al. described three Caucasian patients with
Jaccoud’s arthropathy, HUVS, and cardiac valvulopathy
[2]. Since 2000, three other patients (an African-American
male, a white female, and a Japanese female) have shown
this rare combination of symptoms [3-5]. All six of these
patients showed no detectable antibodies to C1q and had
no kidney involvement. Our patient had MPGN along
with arthropathy, valvulopathy, and HUVS, however, he
was not tested for antibodies to C1q.
In 2002, Houser et al. reported the histological find-
ings of the cardiac valves in these patients [14]. His
histopathology tests revealed vasculitis with fibrinoid ne-
crosis and granulation tissue with numerous inflamma-
tory cells. One patient showed C1q staining in the valve,
and another patient showed prominent deposition ofIgG, IgM, and small amounts of IgA on the valve surface
with immunostaining [14].
In the present case, our patient showed extensive im-
munoglobulin and complement deposition in the glom-
erular capillary loop. The presence of complement and
immunoglobulin in the valvulopathy and glomerulo-
nephritis specimens may be more consistent with dam-
age induced by an immune complex mechanism rather
than by an antibody, as in HUVS.
Our patient was the seventh case of the concurrence
of HUVS, Jaccoud’s arthropathy, and cardiac valvulopathy.
He also developed azotemia associated with membrano-
proliferative glomerulonephritis, unlike other cases. He
was treated with a combination of corticosteroids, cyclo-
phosphamide, and MMF, which stabilized his nephropa-
thy. But his cutaneous vasculitis, cardiac valvulopathy, and
arthropathy remained unchanged.
Conclusions
We describe, to the best of our knowledge, the first case
of glomerulonephritis along with arthropathy, cardiac
valvulopathy, and HUVS. A combination of corticoste-
roids, cyclophosphamide, and MMF appear to be a safe
and effective treatment of nephropathy, however, are less
effective for cutaneous vasculitis, cardiac valvulopathy,
and arthropathy.
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